The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 03, 2024

Filed:

Feb. 09, 2023
Applicant:

Somerset Therapeutics, Llc, Hollywood, FL (US);

Inventors:

Mandar V. Shah, Rockaway, NJ (US);

Ilango Subramanian, Warren, NJ (US);

Veerappan Subramanian, Warren, NJ (US);

Aman Trehan, Hillsborough, NJ (US);

Assignee:

Somerset Therapeutics, LLC, Hollywood, FL (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/4178 (2006.01); A61K 9/00 (2006.01); A61K 9/08 (2006.01); A61K 31/14 (2006.01); A61K 31/498 (2006.01); A61K 47/02 (2006.01); A61K 47/18 (2017.01); A61K 47/26 (2006.01); A61K 47/44 (2017.01);
U.S. Cl.
CPC ...
A61K 31/4178 (2013.01); A61K 9/0048 (2013.01); A61K 9/08 (2013.01); A61K 31/14 (2013.01); A61K 31/498 (2013.01); A61K 47/02 (2013.01); A61K 47/186 (2013.01); A61K 47/26 (2013.01); A61K 47/44 (2013.01);
Abstract

The present invention provides stable, pharmaceutically acceptable and ophthalmologically suitable compositions comprising therapeutically effective amounts of both a pilocarpine compound and a brimonidine compound for treating an ocular condition, the compositions comprising a low amount of sodium chloride present in a limited ratio with the active pharmaceutical ingredient(s). In certain embodiments, provided compositions are free of both a borate buffer and a citrate buffer. Compositions provided by the invention surprisingly demonstrate pharmaceutically acceptable stability characteristics when stored under controlled room temperature conditions for an extended period of time. Further, the invention provides methods of manufacturing such compositions in both liquid (solution) and gel form, and methods of their use in treating ocular conditions, such as presbyopia.


Find Patent Forward Citations

Loading…